Discussion At present, clinical remedy of patients with chronic hepatitis B is mainly on the foundation of regular antiviral treatment, which can improve the patients liver function to a certain extent, turn HBV-DNA negative, delay the process of liver fibrosis, and has a definite impact on ameliorating the patients quality of life and survival rate
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
Regarding other side effects, while GLP1RA themselves are not typically associated with hypoglycemia, when used in combination with other antidiabetic medications, there may be an increased risk of hypoglycemia
BAC water vials can be re-entered with a clean needle within the bottles working window because the benzyl alcohol keeps bacterial growth in check
Qin Y, Yuan W, Deng H, et al